Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.
about
Bisphosphonate therapy in pediatric patientsInnate and adaptive immune cells in the tumor microenvironmentHarnessing the power of Vδ2 cells in cancer immunotherapyRapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis.PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceHepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronateIn vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.Immunosuppressive microenvironment in neuroblastoma.γδ T Cell-Mediated Immune Responses in Disease and TherapyNew immunotherapeutic strategies for the treatment of neuroblastoma.Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma.Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.Zoledronic acid sensitizes rhabdomyosarcoma cells to cytolysis mediated by human γδ T cells.Gamma-delta (γδ) T cells: friend or foe in cancer development?SEC-TID: A Label-Free Method for Small-Molecule Target Identification.Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation.Cerebrospinal fluid γδ T cell frequency is age-related: a case control study of 435 children with inflammatory and non-inflammatory neurologic disorders.Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model.
P2860
Q26830702-B77F4979-7970-43C3-873E-CABF799ABA05Q27008342-875F5EFE-B0CF-49FA-BBA2-4F910ED651E6Q27027547-B17D75BD-7E34-4D6E-9856-69BFD9827198Q35917978-74A05C90-13BC-4E4C-B02D-61BD3898A334Q36597354-950BDBC8-1850-49DF-8E2D-ADA2C8F6A05EQ36734208-30E1D17F-ED0A-4E93-A514-65ACC3FCE0FBQ37354985-F0C4BEC0-C35F-4B10-B2BD-7ECC48DEDD3CQ37605828-4023636D-5B94-4A23-9532-1EBEAD060538Q38117379-32A88C59-3EC0-483E-BBA9-210D2466E189Q38271584-263CA579-87A2-4FA5-8202-63FD3BCC83F0Q38389316-E20165B8-FB38-4551-9AE9-76C82D8257ADQ38811197-F605D3BB-B951-47DF-B013-DCBA9742BD69Q39014899-10ED3C17-0CB5-441A-84C5-6471962FF499Q41016131-8C024238-E952-47BA-BF3A-F07C2C400E69Q47270508-47F7E835-6317-4069-9976-6C963C106764Q47742552-D79AC1CE-E26C-4CA8-BDE1-35857E6C4889Q48019814-DFAB26D1-451A-4A84-83DA-146E584A8F8DQ50025651-CA46BA52-E265-49EF-963A-51B1D7FB4CC4Q50868161-48E7B45A-F8AC-475D-B45B-F141017CD7B9Q51775297-6D51249F-646E-4EAA-AE03-F02A88036185
P2860
Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mechanisms of the antitumor ac ...... inical model of neuroblastoma.
@en
type
label
Mechanisms of the antitumor ac ...... inical model of neuroblastoma.
@en
prefLabel
Mechanisms of the antitumor ac ...... inical model of neuroblastoma.
@en
P2093
P2860
P356
P1433
P1476
Mechanisms of the antitumor ac ...... linical model of neuroblastoma
@en
P2093
Emma Di Carlo
Giuseppe Cipollone
Ignazia Prigione
Laura Emionite
Michele Cilli
Paola Bocca
Vito Pistoia
P2860
P304
P356
10.1038/MT.2013.38
P577
2013-03-12T00:00:00Z